Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure-Reference-Cited by-同舟云学术

Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure

Published:2017-05 Issue:10081 Volume:389 Page:1831-1840
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Packer Milton,McMurray John J V

Publisher

Elsevier BV

Subject

General Medicine

Reference172 articles.

1. Pathophysiology of chronic heart failure;Packer;Lancet,1992

2. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction;Gradman;Am Heart J,2009

3. Local angiotensin II aggravates cardiac remodeling in hypertension;Xu;Am J Physiol Heart Circ Physiol,2010

4. Aldosterone and angiotensin: role in diabetes and cardiovascular diseases;Patel;Eur J Pharmacol,2012

5. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure;Yoshida;Br J Pharmacol,2001

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA Therapeutics for the Cardiovascular System;Circulation;2024-02-27

2. Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity;Cancers;2023-01-03

3. The role of the formation of neutrophil extracellular traps (NETosis) in the pathophysiology and the complications of COVID-19: A review of the literature;Saudi Journal for Health Sciences;2023

4. Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension;Clinical Research in Cardiology;2022-11-03

5. Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases;Oxidative Medicine and Cellular Longevity;2022-10-03